Vol.

No.

April 16, 2021Apr 16, 2021

DOWNLOAD THE PDF

Karen Knudsen named CEO of the American Cancer Society

Cover Story

Conversation with The Cancer Letter Free

Karen Knudsen named CEO of the American Cancer Society

Karen E. Knudsen was named CEO of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network.

NCI Director's Report

Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”

By Matthew Bin Han Ong

Film & TV Free

A film documents deadly aftermath of power morcellation and the campaign to stop it

By Paul Goldberg

Free In the Archives

H. Lee Moffitt, and 11 years of NCCS Networker archives

Clinical Trials & Tribulations

Best practices in preventing heartbreak:
A look at a SWOG cancer control trial

By Justin Floyd and Monika Leja

In Brief

David Tuveson inaugurated president of AACR; Lisa Coussens is president-elect

Ludwig Institute opens cancer metabolism branch at Princeton

Carl June receives $1M Sanford Lorraine Cross Award

Marcos J. de Lima named director of Bone Marrow Transplant Services at OSUCCC – James

Patrizia Cavazzoni named permanent director of FDA CDER

Mark Juckett named medical director of the Masonic’s immuno-oncology initiative

Laura Baum named assistant professor at Yale Cancer Center and Smilow Cancer Hospital

Six researchers receive NCCN Young Investigator Awards

COA, CancerCare establish “Time to Screen” campaign to boost cancer screenings

Sens. Richard Burr and Ben Cardin recognized as ASCO Congressional Champions for Cancer Care

Clinical Roundup

Yale Cancer Center study shows young early-onset colorectal cancer patients have increased survival

Level of chromosomal abnormality in NSCLC may predict response to immunotherapy

CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma

PanCAN initiates $25M study on potential link between pancreatic cancer and diabetes after age 50

Drugs & Targets

Trodelvy receives FDA accelerated approval for advanced urothelial cancer

GI Genius receives marketing authorization from FDA to detect potential signs of colon cancer

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues